HCW Biologics Inc (HCWB) Stock: Assessing the Risk and Reward

The stock of HCW Biologics Inc (HCWB) has gone down by -28.19% for the week, with a -41.38% drop in the past month and a -46.64% drop in the past quarter. The volatility ratio for the week is 12.53%, and the volatility levels for the past 30 days are 11.67% for HCWB. The simple moving average for the past 20 days is -32.71% for HCWB’s stock, with a -67.01% simple moving average for the past 200 days.

Is It Worth Investing in HCW Biologics Inc (NASDAQ: HCWB) Right Now?

The 36-month beta value for HCWB is at 0.77. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The public float for HCWB is 19.75M, and currently, shorts hold a 0.04% of that float. The average trading volume for HCWB on November 12, 2024 was 27.55K shares.

HCWB) stock’s latest price update

HCW Biologics Inc (NASDAQ: HCWB)’s stock price has gone decline by -14.10 in comparison to its previous close of 0.36, however, the company has experienced a -28.19% decrease in its stock price over the last five trading days. globenewswire.com reported 2024-08-23 that This release has made a correction to a release issued under the same headline on August 14, 2024, by HCW Biologics, Inc. (NASDAQ: HCWB), to show the amount included in the condensed interim balance sheet for Cash and cash equivalents as of December 31, 2023 as $3,595,101, not $95,101 as previously stated. The full text of the corrected release is as follows: MIRAMAR, Fla.

HCWB Trading at -39.06% from the 50-Day Moving Average

After a stumble in the market that brought HCWB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -83.96% of loss for the given period.

Volatility was left at 11.67%, however, over the last 30 days, the volatility rate increased by 12.53%, as shares sank -43.97% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -22.62% lower at present.

During the last 5 trading sessions, HCWB fell by -24.59%, which changed the moving average for the period of 200-days by -70.45% in comparison to the 20-day moving average, which settled at $0.4607. In addition, HCW Biologics Inc saw -74.73% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for HCWB

Current profitability levels for the company are sitting at:

  • -6.83 for the present operating margin
  • 0.15 for the gross margin

The net margin for HCW Biologics Inc stands at -9.78. The total capital return value is set at -7.44. Equity return is now at value -344.32, with -115.73 for asset returns.

Based on HCW Biologics Inc (HCWB), the company’s capital structure generated 2.69 points at debt to capital in total, while cash flow to debt ratio is standing at -1.79. The debt to equity ratio resting at -1.59. The interest coverage ratio of the stock is -105.54.

Currently, EBITDA for the company is -24.58 million with net debt to EBITDA at -0.35. When we switch over and look at the enterprise to sales, we see a ratio of 5.2. The receivables turnover for the company is 5.99for trailing twelve months and the total asset turnover is 0.15. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.10.

Conclusion

In conclusion, HCW Biologics Inc (HCWB) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts